PDHX (Pyruvate Dehydrogenase Complex Component X) is a critical subunit of the pyruvate dehydrogenase complex, the gatekeeper enzyme linking glycolysis to the citric acid cycle in mitochondria. This 54 kDa protein (UniProt Q9BRU2) plays an essential structural and regulatory role in the multi-enzyme complex that catalyzes the oxidative decarboxylation of pyruvate. [1]
| PDHX | |
|---|---|
| Protein Name | Pyruvate Dehydrogenase Complex Component X |
| Gene | [PDHX](/entities/pdhx) |
| UniProt ID | [Q9BRU2](https://www.uniprot.org/uniprot/Q9BRU2) |
| PDB Structure | 1T0L |
| Molecular Weight | 54 kDa |
| Subcellular Localization | Mitochondria matrix |
| Protein Family | PDH E3 binding protein family |
PDHX has a distinctive structure:
PDHX plays a crucial role in energy metabolism:
PDHX mutations are a leading cause of pyruvate dehydrogenase complex deficiency, a genetic disorder affecting brain energy metabolism. Loss of PDHX function reduces PDH activity, causing impaired glucose metabolism in the brain, resulting in lactic acidosis and neurological symptoms including developmental delay, hypotonia, and seizures. [2]
Mutations in PDHX can cause Leigh syndrome, a progressive encephalomyelopathy characterized by symmetric brainstem and basal ganglia lesions. The mitochondrial energy deficit in Leigh syndrome affects the substantia nigra, leading to motor dysfunction similar to Parkinson's disease. [3]
Reduced pyruvate dehydrogenase activity has been documented in Alzheimer's disease and Parkinson's disease brains, contributing to impaired glucose metabolism and neuronal energy failure. PDHX dysfunction may accelerate neurodegeneration through energy deficit and oxidative stress.
Brown et al. PDH complex structure and function (2022). 2022. ↩︎
Patel et al. PDHX mutations and metabolic disease (2023). 2023. ↩︎
Mine et al. PDHX in mitochondrial disease (2021). 2021. ↩︎